Combination chemotherapy for marrow relapse in children and adolescents with acute lymphocytic leukaemia. 1981

S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli

38 children with acute lymphocytic leukaemia (ALL) in haematologic relapse were retreated with vincristine, daunomycin and prednisone (VPD) together with intrathecal methotrexate and prednisone, followed by asparaginase in those patients not in complete remission after 4 weeks. The overall complete remission (CR) rate was 79%; asparaginase was needed to achieve CR in 7 of the 30 responding patients. The median duration of second remission was only 36 weeks, but 6 out of 15 children receiving the COAP-POMP-CART consolidation regimen remain in continuous second remission after 37-260 weeks; 3 of them are currently off all therapy. It is concluded that a prolonged second remission can be achieved in children with ALL in bone marrow relapse by combining intensive chemotherapy with the prevention of meningeal leukaemia.

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
August 1985, Scandinavian journal of haematology,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
March 1982, Blut,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
January 1979, Medical and pediatric oncology,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
September 1975, Archives of disease in childhood,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
January 1978, American journal of hematology,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
December 1979, British journal of cancer,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
September 1983, Cancer treatment reviews,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
May 2007, The Australasian journal of dermatology,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
October 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Amadori, and M A Spiriti, and G Meloni, and L Pacilli, and G Papa, and F Mandelli
May 2009, Journal of clinical pathology,
Copied contents to your clipboard!